Introduction
Rapid activation of the mononuclear phagocytic system is critical for limiting bacterial burden and promoting resistance to infection (Chow
et al,
2011). However, the activation of the immune system is an energetically and nutritionally demanding process requiring a coordinated response of almost all organs and tissues within the organism (Rankin & Artis,
2018). Although metabolic reprogramming accompanies virtually any immune response and can profoundly affect patient health (Chi,
2022), the mechanism coordinating the immune response with systemic metabolism remains poorly understood.
Upon recognition of a pathogen, macrophages adopt a pro‐inflammatory polarization to enhance their bactericidal capacity and secrete pro‐inflammatory cytokines that propagate information about the pathogenic threat to other tissue in the body (Mills
et al,
2000). This polarization is achieved by stabilizing the transcription factor HIF1α that governs the complex rewiring of macrophage cellular metabolism, which is generally referred to as aerobic glycolysis (Galvan‐Pena & O'Neill,
2014). However, this metabolic adaptation leads to the rapid depletion of macrophage intracellular stores and makes them functionally dependent on external sources of nutrients (Ganeshan & Chawla,
2014).
Along with the rewiring of the cellular metabolism of the immune cells, systemic metabolism also exhibits substantial adjustments. For example, altered hormonal signaling, and subsequent disruption of metabolic homeostasis manifested by loss of nutritional stores and their enhanced level in circulation (hyperglycemia, hyperlipidemia), are commonly observed accompanying signs in patients suffering from severe bacterial infections (Wasyluk & Zwolak,
2021).
Recently, insulin resistance has been considered an adaptive mechanism of energy redistribution during acute metabolic stress (Tsatsoulis
et al,
2013). However, this concept is in stark contrast to the common perception of insulin resistance as a pathological process associated with obesity, atherosclerosis, arthritis, and cachexia (Akhtar
et al,
2019), and the possible adaptive role of insulin resistance has been neglected so far. Interestingly, the increased production of pro‐inflammatory cytokines by the activated immune system plays a central role in the induction of insulin resistance and the progression of the diseases mentioned above (Al‐Mansoori
et al,
2022).
In this work, we aim to investigate the factors inducing the mobilization of nutrients required to supplement the nutritional demands of the activated immune system.
To reveal the role of macrophages in the regulation of systemic metabolism during the immune response, we employed an established experimental model of streptococcal infection in
Drosophila (Bajgar & Dolezal,
2018). Exploiting this experimental system, we have previously demonstrated that
Drosophila macrophages undergo pro‐inflammatory polarization in response to bacterial infection associated with HIF1α‐driven aerobic glycolysis in a manner analogous to that observed in mammals (Krejčová
et al,
2019). Moreover, streptococcal infection in this model is accompanied by substantial remodeling of systemic carbohydrate and lipid metabolism (Dionne & Schneider,
2008; Bajgar & Dolezal,
2018).
Here we demonstrate that pro‐inflammatory macrophage polarization is coupled with the production of the signaling factor IMPL2, which alleviates insulin signaling in the central metabolic organ of flies, the fat body. Macrophage‐derived IMPL2 is required for the mobilization of lipid stores in the form of lipoproteins, which is fundamental for the nutritional supplementation of bactericidal macrophages and resistance to infection. Our data further imply that this mechanism is evolutionarily conserved in mammals. Indeed, mammalian macrophages produce the mammalian ImpL2 homolog Insulin growth factor binding protein 7 (IGFBP7), which induces the mobilization of lipoproteins from hepatocytes during bacterial infection.
Discussion
The pro‐inflammatory polarization of macrophages is associated with extraordinary energy and nutritional demands that must be supplemented from external sources (Newsholme,
2021). To fight infection, an organism must significantly adjust systemic metabolism and relocate nutrients from stores toward the immune system (Ganeshan
et al,
2019). In this regard, induction of insulin resistance has been proposed as a potentially adaptive mechanism for metabolic adaptation to infection (DiAngelo
et al,
2009). However, the signal reflecting the nutritional demands of the activated immune system and the mechanism underlying the systemic metabolic changes remain largely unknown. In this work, we employed a model of bacterial infection in
Drosophila to reveal the mechanism connecting the metabolic remodeling of activated macrophages to a systemic metabolic switch.
In our previous work, we described that infection‐activated
Drosophila macrophages adopt aerobic glycolysis driven by the transcription factor HIF1α as a predominant metabolic pathway for energy production (Kedia‐Mehta & Finlay,
2019; Krejčová
et al,
2019). Here, we extend this observation and show that infection‐activated macrophages exhibit increased lipid uptake and utilization in addition to aerobic glycolysis. Moreover, here we found that HIF1α activity leads to increased production of the signaling factor IMPL2 in these cells. Given that HIF1α is a crucial transcription factor governing the M1 metabolic shift (Corcoran & O'Neill,
2016), IMPL2 can be perceived as a signal translating the increased nutritional demands of activated macrophages to systemic metabolism.
It has been documented that IMPL2 is also secreted by genetically induced neoplastic tumors (Kwon
et al,
2015), hypoxic muscles (Owusu‐Ansah
et al,
2013), and inflamed guts (Hang
et al,
2014). Thus, IMPL2 production is not under all circumstances restricted exclusively to immune cells and may be coupled to strong metabolic activity and suddenly increased nutritional demands of virtually any tissue. Thus, the regulatory role of
ImpL2 may be crucial for the redistribution of resources during metabolic stress, and IMPL2 activity is not limited to pathological stress situations but may also have adaptive evolutionary significance.
Enhanced IMPL2 production has been shown to invoke systemic metabolic changes resembling cachexia‐like wasting, leading to the depletion of lipid stores in the central metabolic organ (Figueroa‐Clarevega & Bilder,
2015; Kwon
et al,
2015). Bacterial infection and subsequent activation of immune‐related cascades in the fat body leads to dramatic changes in its physiology and metabolism leading to mobilization of lipids as a part of the antibacterial immune response (Martínez
et al,
2020; Zhao & Karpac,
2021). Consistent with this, we found that the production of IMPL2 by activated macrophages induces the mobilization of lipid stores from the fat body, leading to an elevated level of lipids in circulation and their subsequent accumulation in activated immune cells. The mechanism underlying the effects of IMPL2 can be attributed to the alleviation of insulin signaling in the fat body, resulting in enhanced FOXO–induced mobilization of lipoproteins. This is consistent with the previous observation that IMPL2 exhibits a high affinity for circulating
Drosophila insulin‐like peptides, thus acting as a potent inhibitor of insulin signaling and coordinating larval growth and development (Honegger
et al,
2008). Even though our data indicate that macrophage‐derived IMPL2 induces mobilization of lipoproteins from the fat body, the participation of direct transport of dietary lipids toward activated immune cells cannot be excluded. Some of our data, however, do not support this eventuality. Analysis of lipid content in the gut indicates that infection leads to enhanced retention of lipids in this organ. Moreover, although genetic manipulation of
ImpL2 expression in macrophages affects the expression of
Apoltp in the fat body, which is thought to be responsible for lipid transport from the gut, this manipulation does not affect gut lipid content significantly. We may thus speculate that in
Drosophila,
Apoltp may play a role in both lipid transport from the gut and mobilization of lipids from the fat body, as has been shown in other insect species (Arrese
et al,
2001; Canavoso
et al,
2004). Nevertheless, further investigation is needed in this regard.
Recently, it has been proposed that IMPL2 activity may cause the metabolic adaptations observed in the reproductive cast of ants that are required for the maturation of the ovaries, but the mechanism underlying this process has not been fully elucidated (Yan & Horng,
2020). Thus, our proposed mechanism of action of IMPL2 explains this phenomenon well.
We found that IMPL2 production interconnects the metabolic switch of activated macrophages to the mobilization of lipoproteins to supplement the metabolic needs associated with the bactericidal function of the immune system. Interventions of this mechanism at the level of IMPL2 production by macrophages, or lipoprotein mobilization from the fat body compromise the ability of macrophages to fight the bacterial pathogen, resulting in deterioration of the individual's resistance to infection. Thus, IMPL2‐mediated metabolic changes are essential for an adequate immune response to extracellular bacteria. The presented data indicate that activated macrophages must be supplemented by lipids from external sources to fight the pathogen efficiently. The increased uptake and accumulation of lipids by infection‐activated macrophages may be attributed to their use for cell membrane remodeling, catecholamine synthesis, and epigenetic reprograming (Remmerie & Scott,
2018; Yan & Horng,
2020). Nonetheless, the link between increased lipid utilization and the bactericidal activity of
Drosophila macrophages has not yet been satisfactorily elucidated.
Our data from mice and human experimental systems suggest that an analogous mechanism may be evolutionarily conserved. The
ImpL2 homolog
IGFBP7 is produced by liver macrophages upon their proinflammatory polarization and possesses the potential to induce the mobilization of LDL and VLDL from hepatocytes. Although the mechanism of IGFBP7 action on hepatocytes was not addressed in this study, we have previously shown that IGFBP7 binds directly to the insulin receptor in hepatocytes and induces systemic metabolic changes via regulation of ERK signaling in the liver (Roed
et al,
2018). Our model is analogous to observations in obese mice and humans in which hepatic insulin resistance induces constitutive FOXO activation leading to increased lipoprotein production (Yan & Horng,
2020). Nonetheless, the effect of IGFBP7 and other cytokines on the mobilization of lipoproteins from the liver during bacterial infection requires further investigation.
Of particular note is the control of
ImpL2/
IGFBP7 by the transcription factor HIF1α. In addition to the role of HIF1α in macrophage polarization during infection, increased activity of this transcription factor is a hallmark of progressive obesity and obesity‐related diseases such as non‐alcoholic fatty liver disease and atherosclerosis (Izquierdo
et al,
2022). Therefore, the initially adaptive production of pro‐inflammatory cytokines under HIF1α control may become maladaptive in the case of chronic macrophage polarization in adipose tissue and the liver.
In the context of the presented results, the cytokine‐induced alleviation of insulin signaling in the liver may represent an initially adaptive mechanism by which macrophages secure nutrients for the function of the immune system during bacterial infection. However, chronic activation of this signaling in an infection‐independent context may lead to the development of metabolic diseases.
Materials and Methods
Drosophila melanogaster strains and culture
The flies were raised on a diet containing cornmeal (80 g/l), sucrose (50 g/l), yeast (40 g/l), agar (10 g/l), and 10%‐methylparaben (16.7 ml/l) and maintained in a humidity‐controlled environment with a natural 12 h/12 h light/dark cycle at 25°C. Flies carrying Gal80 protein were raised at 18°C and transferred to 29°C 24 h before infection in order to degrade temperature‐sensitive Gal80. Prior to the experiments, both experimental and control flies were kept in plastic vials on a sucrose‐free cornmeal diet (cornmeal 53.5 g/l, yeast 28.2 g/l, agar 6.2 g/l and 10%‐methylparaben 16.7 ml/l) for 7 days. Flies infected with
S. pneumoniae were kept on a sucrose‐free cornmeal diet in incubators at 29°C due to the temperature sensitivity of
S. pneumoniae. Infected individuals were transferred to fresh vials every other day without the use of CO
2 to ensure good food conditions.
Bacterial strain and fly injection
The Streptococcus pneumoniae strain EJ1 was stored at −80°C in Tryptic Soy Broth (TSB) media containing 10% glycerol. For the experiments, bacteria were streaked onto agar plates containing 3% TSB and 100 mg/ml streptomycin and subsequently incubated at 37°C in 5% CO2 overnight. Single colonies were inoculated into 3 ml of TSB liquid media with 100 mg/ml of streptomycin and 100,000 units of catalase and incubated at 37°C + 5% CO2 overnight. Bacterial density was measured after an additional 4 h so that it reached an approximate 0.4 OD600. Final bacterial cultures were centrifuged and dissolved in PBS so the final OD reached 2.4. The S. pneumoniae culture was kept on ice before injection and during the injection itself. Seven‐day‐old males were anesthetized with CO2 and injected with a 50 nl culture containing 20,000 S. pneumoniae bacteria or 50 nl of mock buffer (PBS) into the ventrolateral side of the abdomen using an Eppendorf Femtojet microinjector.
Survival analysis
Streptococcus‐injected flies were kept at 29°C in vials with approximately 30 individuals per vial and were transferred to fresh food every other day. Dead flies were counted daily. At least three independent experiments were performed and combined into a single survival curve generated in GraphPad Prism software; individual experiments showed comparable results. The average number of individuals was more than 500 for each genotype and replicate.
Pathogen load measurement
Single flies were homogenized in PBS using a motorized plastic pestle in 1.5 ml tubes. Bacteria were plated in spots onto TSB (S. pneumoniae) agar plates containing streptomycin in serial dilutions and incubated overnight at 37°C before manual counting. Pathogen loads of 16 flies were determined for each genotype and treatment in each experiment; at least three independent infection experiments were conducted and the results were combined into one graph (in all presented cases, individual experiments showed comparable results).
Isolation of macrophages
GFP‐labeled macrophages were isolated from
Crq > Gal4 UAS‐eGFP male flies using fluorescence‐activated cell sorting (FACS; Krejčová
et al,
2019). Approximately 200 flies were anesthetized with CO
2, washed in PBS, and homogenized in 600 ml of PBS using a pestle. The homogenate was sieved through a nylon cell strainer (40 μm). This strainer was then additionally washed with 200 μl of PBS, which was added to the homogenate subsequently. The samples were centrifuged (3 min, 4°C, 3,500 rpm) and the supernatant was washed with ice‐cold PBS after each centrifugation (three times). Before sorting, samples were transferred to FACS polystyrene tubes using a disposable bacterial filter (50 μm, Sysmex) and macrophages were sorted into 100 μl of PBS using an S3™ Cell Sorter (BioRad). Isolated cells were verified by fluorescence microscopy and differential interference contrast. Different numbers of isolated macrophages were used in different subsequent analyses. To this end, different numbers of flies were used for their isolation, specifically 90 flies were used to isolate 20,000 macrophages for qPCR analysis; approximately 160 flies were used to isolate 50,000 macrophages for metabolic analysis; approximately 300 flies were used to isolate 100,000 and 200,000 macrophages for lipidomic and transcriptomic analyses.
Gene expression analysis
Gene expression analyses were performed on several types of samples: six whole flies, six thoraxes, six fat bodies, or 20,000 isolated macrophages. For a description of the dissection procedure see Appendix Fig
S25. Macrophages were isolated by a cell sorter (S3e Cell Sorter, BioRad) as described previously (Krejčová
et al,
2019) while dissections were made in PBS, transferred to TRIzol Reagent (Invitrogen), and homogenized using a DEPC‐treated pestle. Subsequently, RNA was extracted by TRIzol Reagent (Invitrogen) according to the manufacturer's protocol. Superscript III Reverse Transcriptase (Invitrogen) primed by oligo(dT)20 primer was used for reverse transcription. Relative expression rates for particular genes were quantified on a 384CFX 1000 Touch Real‐Time Cycler (BioRad) using the TP 2x SYBR Master Mix (Top‐Bio) in three technical replicates with the following protocol: initial denaturation—3 min at 95°C, amplification—15 s at 94°C, 20 s at 56°C, 25 s at 72°C for 40 cycles. Melting curve analysis was performed at 65–85°C/step 0.5°C. The primer sequences are listed in the Key Resources Table. The qPCR data were analyzed using double delta Ct analysis, and the expressions or specific genes were normalized to the expression of Ribosomal protein 49 (Rp49) in the corresponding sample. The relative values (fold change) to control are shown in the graphs.
Metabolite measurement
To measure metabolite concentration, isolated macrophages, whole flies, fat bodies, or hemolymph (circulation) were used. Hemolymph was isolated from 25 adult males by centrifugation (14,000 rpm, 5 min) through a silica‐gel filter into 50 μl of PBS. For measurement of metabolites from whole flies, five flies were homogenized in 200 μl of PBS and centrifuged (3 min, 4°C, 8,000 rpm) to discard insoluble debris. 50,000 macrophages were isolated by cell sorter (S3e Cell Sorter, BioRad) as described in the section Isolation of macrophages. For analysis of fat body metabolites, the fat body from six flies was dissected and homogenized in ice‐cold PBS. Fraction of fat body was used for quantification of carbohydrates and part was used for isolation of lipid fraction by adapted Bligh and Dyer method for assaying of cholesterol, cholesteryl‐ester, and triglycerides. The concentration of metabolites was normalized per protein in the sample. Half of all samples were used for the quantification of proteins. Samples for glucose, glycogen, trehalose, and glyceride measurement were denatured at 75°C for 10 min, whereas samples for protein quantification were frozen immediately at −80°C. Glucose was measured using a Glucose (GO) Assay (GAGO‐20) Kit (Sigma) according to the manufacturer's protocol. The colorimetric reaction was measured at 540 nm. For glycogen quantification, a sample was mixed with amyloglucosidase (Sigma) and incubated at 37°C for 30 min. A Bicinchoninic Acid Assay (BCA) Kit (Sigma) was used for protein quantification according to the supplier's protocol and the absorbance was measured at 595 nm. Cholesterol and cholesteryl esters were measured on isolated lipid fractions by using Cholesterol/Cholesteryl Ester Quantitation Kit (Sigma) according to the supplier's protocol. Glycerides were measured using a Triglyceride quantification Colorimetric/Fluorometric Kit (Sigma). For trehalose quantification, a sample was mixed with trehalase (Sigma) and incubated at 37°C for 30 min. Samples for metabolite concentration were collected from three independent experiments.
Staining of lipid droplets
Flies were dissected in Grace's Insect Medium (Sigma) and subsequently stained with DAPI and Cell Brite Fix Membrane Stain 488 (Biotium) diluted with Grace's Insect Medium according to the manufacturer's protocol at 37°C. Tissues were washed in PBS and then fixed with 4% PFA (Polysciences). After 20 min, the tissues were washed in PBS and pre‐washed with 60% isopropanol. Dissected abdomens were then stained with OilRedO dissolved in 60% isopropanol for 10 min. The tissues were then washed with 60% isopropanol and mounted in an Aqua Polymount (Polysciences). Tissues were imaged using an Olympus FluoView 3000 confocal microscope (Olympus). The content of lipids in adipose tissue and the size of lipid droplets were analyzed using Fiji software. Flies for the analysis of lipid droplets in the fat body were collected from three independent experiments and representative images are shown.
Lipidomic analysis
Fat bodies from six flies and one hundred thousand isolated macrophages were obtained for each analyzed group. Tissue lipid fraction was extracted by 500 μl of cold chloroform: methanol solution (v/v; 2:1). The samples were then homogenized by a Tissue Lyser II (Qiagen, Prague, Czech Republic) at 50 Hz, −18°C for 5 min and kept further in an ultrasonic bath (0°C, 5 min). Further, the mixture was centrifuged at 10,000 rpm at 4°C for 10 min followed by the removal of the supernatant. The extraction step was repeated under the same conditions. The lower layer of pooled supernatant was evaporated to dryness under a gentle stream of Argon. The dry total lipid extract was re‐dissolved in 50 μl of chloroform: methanol solution (v/v; 2:1) and directly measured using previously described methods (Bayley
et al,
2020). Briefly, high‐performance liquid chromatography (Accela 600 pump, Accela AS autosampler) combined with mass spectrometry LTQ‐XL (all Thermo Fisher Scientific, San Jose, CA, USA) were used. The chromatographic conditions were as follows: Injection volume 5 μl; column.
Gemini 3 μM C18 HPLC column (150 × 2 mm ID, Phenomenex, Torrance, CA, USA) at 35°C; the mobile phase (A) 5 mM ammonium acetate in methanol with ammonia (0.025%), (B) water and (C) isopropanol: MeOH (8:2); gradient change of A:B:C as follows: 0 min: 92:8:0, 7 min: 97:3:0, 12 min: 100:0:0, 19 min: 93:0:7, 20–29 min: 90:0:10, 40–45 min: 40:0:60, 48 min: 100:0:0, and 50–65 min: 92:8:0 with flow rate 200 μl/min. The mass spectrometry condition: positive (3 kV) and negative (−2.5 kV) ion detection mode; capillary temperature 200°C. Eluted ions were detected with full scan mode from 200 to 1,000 Da with the collisionally induced MS2 fragmentation (NCE 35). Data were acquired and processed by means of XCalibur 4.0 software (Thermo Fisher). The corrected areas under individual analytical peaks were expressed in percentages assuming that the total area of all detected is 100%. Lipidomics data were subsequently analyzed in the online platform LipidSuite (
https://suite.lipidr.org/; Mohamed & Hill,
2021). Data were inputted by the K‐Neares Neighbors method (KNN), and normalization was performed by the PQN algorithm. Subsequently, data were explored by PCA and OPLS‐DA methods. Differential analysis of lipidomic data was done by univariate analysis and visualized in Volcano plots.
Immunostaining
Flies were dissected in ice‐cold PBS and fixed with 4% PFA in PBS (Polysciences) for 20 min. After three washes in PBS‐Tween (0.1%), nonspecific binding was blocked by 10% NGS in PBS for 1 h at RT. Tissues were then incubated with primary antibodies (for NimC1: Mouse anti‐NimC1 antibody P1a + b, 1:100, kindly provided by István Andó (Kurucz
et al,
2007); for Foxo: Rabbit anti‐Foxo, CosmoBio, 1:1,000; for tGPH: Rabbit anti‐GFP, ABfinity, 1:100) at 4°C overnight. After washing the unbound primary antibody (three times for 10 min in PBS‐Tween), the secondary antibody was applied at a dilution of 1:250 for 2 h at RT (Goat anti‐Mouse IgG (H + L) Alexa 555, Invitrogen or Goat anti‐Rabbit IgG (H + L) Cy2, Jackson‐Immunoresearch). Nuclei were stained with DAPI. Tissues were mounted with Aqua Polymount (Polysciences). Tissues were imaged using an Olympus FluoView 3000 confocal microscope (Olympus) and images were reconstructed using Fiji software. Foxo localization was detected by Plot‐Profile analysis using Fiji software. For tGPH activity, confocal images were analyzed by using a plot profile (FIJI) under an arbitrarily defined line connecting two nuclei of neighboring cells and crossing the membrane in the middle. The ratio between cytosolic and membrane signals is displayed in the plot.
Incorporation of 13C free fatty acids
For assaying 13C‐FFA distribution post‐infection, males were fed standard fly food covered on its surface with 50 μl
13C Fatty Acid Mix (Cambridge Isotope Laboratories), 5 mg/ml in chloroform per each vial for 5 h. After 5 h FFAs can be detected in the gut, but are not incorporated into other body compartments (as documented by Bodipy‐labeled FFAs). Thereafter, the flies were split into control and experimental groups and injected with buffer or
S. pneumoniae, and transferred to a fresh vial containing unlabeled food. After 24 h, six guts and six fat bodies were dissected in PBS and 50,000 macrophages were isolated by cell sorter from 160 individuals. Lipid fraction from the samples was isolated through the standard Bligh and Dyer procedure and free fatty acids were deliberated from complexes by a lipase from
Aspergillus niger. Homogenized and filtered chloroform extracts (100 μl) were put in glass inserts in 2 ml chromatographic vials and their 13C enrichment was analyzed compound‐specific. 1 μl was injected in a split/splitless injector of a gas chromatograph, GC (Trace 1310, Thermo, Bremen, Germany), injector at 250°C. The injection was splitless for 1.5 min, then split with flow 100 ml/min for the next 1 min, and 5 ml/min (gas saver) for the rest of the analysis. Semipolar capillary column Zebron, ZB‐FFAP (Phenomenex, Torrance CA, USA, 30 m × 0.25 mm × 0.25 μm film thickness) with a flow rate of 1.5 ml/min of helium was used as a carrier. The temperature program was: 50°C during injection and for the next 2 min, then 50–200°C with a slope of 30°C/min, 200–235°C with a slope of 3°C/min, and hold at 235°C for the rest 32 min (total run time ca 51 min). Eluting compounds were oxidized to CO
2 via IsoLink II interphase (Thermo, Bremen, Germany) at 1000°C and introduced to continuous‐flow isotope ratio MS (Delta V Advantage, Thermo, Bremen, Germany). Compounds were identified using retention times of fatty acid standards. 13C sample abundance was expressed in At‐% 13C and “13C excess” calculated as follow:
where A13Cs is the absolute 13C abundance of labeled samples and A13Cn absolute 13C abundance of natural lipids.
Transcriptomic analysis
For transcriptomic analysis, macrophages from flies infected by
S. pneumoniae or injected with PBS were isolated by cell sorter as described in the section “Isolation of macrophages”. Two hundred thousand macrophages were used for the isolation of RNA by TRIzol (Ambion). Sequenation libraries were prepared by using siTOOLs riboPOOL
D. melanogaster RNA kit (EastPort) followed by subtraction of ribosomal fraction by NEBNext Ultra II Directional RNA kit (Illumina). The quality of prepared RNA libraries was assayed by Bioanalyzer and all samples reached an RIN score over the threshold of 7. Sequencing analysis was performed by using the NovaSeq instrument (Illumina). Raw sequencing data were processed by standard bioinformatics workflow for trimming barcodes and adapters. Trimmed reads were aligned to reference
D. melanogaster genome BDGP6.95 (Ensembl release). Trimming, mapping, and analysis of quality were performed in CLC Genomic Workbench 21.0.5 software via standard workflow for RNA‐seq and Differential gene expression analysis. A subsequent search of transcriptomic data for enhanced and silenced pathways and biological processes was done by using TCC (Sun
et al,
2013), and iDep94 (Ge
et al,
2018) platforms combined with String and FlyMine databases.
Chip‐qPCR assay
The Pro‐A Drosophila CHIP Seq Kit (Chromatrap) was used to co‐immuno‐precipitate genomic regions specifically bound by the transcription factor HIF1α. A transgenic fly strain carrying the Hif1α protein fused to GFP (BDSC: 42672) was used for this purpose. The procedure was performed according to the supplier's instructions. Briefly, the slurry was prepared by homogenizing 10 infected or PBS‐injected males in three biological replicates. The Rabbit Anti‐GFP antibody (ABfinity) was bound to the chromatographic column. Genomic DNA was fragmented to an approximate size of 500 bp by three cycles of 60‐s sonication. The fragment size was verified by gel electrophoresis. All samples were tested with positive and negative controls. The amount of precipitated genomic fragments was normalized to the number of fragments in the slurry before precipitation. The ImpL2‐RA promoter sequence was covered with seven primer pairs corresponding to the 500‐bp bins upstream of the transcription start site previously assessed in the in silico analysis. The genomic region of S‐adenosylmethionine synthetase was used as a negative control since it does not contain any sequences of hypoxia response elements. Primer sequences are listed in the Key Resources Table. The amount of HIF1α‐bound regions of the ImpL2 promoter was quantified on a 96CFX 1000 Touch Real‐Time Cycler (BioRad) using TP 2× SYBR Master Mix (Top‐Bio) in three technical replicates with the following protocol: initial denaturation—3 min at 95°C, amplification—15 s at 94°C, 20 s at 56°C, 25 s at 72°C for 40 cycles. Melting curve analysis was performed at 65–85°C/step 0.5°C. The qPCR data were analyzed using double delta Ct analysis.
Phagocytic activity
To analyze the phagocytic rate, flies were infected with 20,000 S. pneumoniae and after 24 h, they were injected with 50 nl of pHrodo™ Red S. aureus (Thermo Fischer Scientific). After 1 h, the abdomens of flies were dissected in PBS and then fixed for 20 min with 4% PFA. Aqua Polymount (Polysciences) was used to mount the sample. Macrophages were imaged using an Olympus FluoView 3000 confocal microscope and red dots depicting phagocytic events were manually counted per cell.
Lipoprotein uptake
To analyze lipoprotein uptake by Drosophila macrophages, Buff injected or infected Crq > GFP flies were injected at 24 hpi with pHrodo™ Red LDL (Invitrogen) into the ventrolateral side of the abdomen using an Eppendorf Femtojet microinjector. After 1 h, the fly abdomens were opened in PBS and subsequently fixed for 20 min with 4% PFA in PBS (Polysciences). Aqua Polymount (Polysciences) was used to mount the sample. Macrophages were imaged using an Olympus FluoView 3000 confocal microscope. LDL pHrodo signal was counted manually from 10 flies for each group.
THP‐1 cell lines
THP‐1 cells were cultured at 37°C, 5% CO2, in RPMI‐1640 medium (Sigma), supplemented with 2 mM glutamine (Applichem), 2 g/l sodium bicarbonate (J&K Scientific), 10% FBS (Biosera) and 100 mg/l streptomycin (Sigma). Prior to the experiment, cells were transferred to 24‐well plates at 105 cells/well in four biological replicates. THP‐1 cells were activated with phorbol‐12‐myristate‐13‐acetate (200 ng/ml, MedChemExpress). After 24 h, S. pneumoniae bacteria were added (MOI 50 bacteria/macrophage) or LPS (100 ng/ml; and the plate was centrifuged briefly (2 min, 200 g). Following 6‐h incubation, the cells were washed with RPMI‐1640 medium, and fresh RPMI‐1640 supplemented with gentamycin (0.1 mg/ml, Sigma) was added. After 1 h incubation, the medium was replaced with RPMI‐1640 supplemented with penicillin–streptomycin (1%, Biosera). After another 17 h, the cells were harvested into TRIzol Reagent (Invitrogen) followed by RNA isolation. In experiments with Hif1α agonist (DMOG—50 mg/ml) and antagonist (KC7F2—25 mg/ml), the Hif1a‐affecting drugs were administered 24 h before exposure of cells to LPS. DMSO was used instead of drug treatments in controls. For quantification of IGFBP7 concentration, the media were harvested and diluted 1:10. IGFBP7 protein level was quantified according to the manufacturer's protocol (Human IGFBP7/Igfbp Rp1 ELISA Kit PicoKine, BosterBio).
Expression analysis of IGFBP7 in mice and human LMs and transcriptomic analysis of hepatocytes
Isolation of RNA, real‐time qPCR and RNA library preparation
RNA extraction and purification were performed by using TRIzol reagent according to the manufacturer's instructions (Thermo Fisher Scientific, 15596018). For real‐time qPCR, cDNA was synthesized from 0.5 μg of total RNA with the iScript cDNA Synthesis kit (Bio‐Rad) according to the manufacturer's instructions. Synthesized cDNA along with forward and reverse primers and Advanced Universal SYBR Green Supermix was run on a CFX96 Real‐Time PCR System (Bio‐Rad). β‐actin (Actb) was used as a reference gene in mice and humans. RNA integrity was determined with an Agilent Bioanalyzer. Libraries from mouse RNA were prepared with the TruSeq Stranded mRNA kit (Illumina) and libraries from human RNA were prepared with the SMARTer Ultra‐Low RNA kit (Clontech). The concentration of the indexed libraries was determined by real‐time qPCR using the Universal Kapa Library Quantification kit (KAPA Biosystems). Final libraries were normalized and sequenced on an Illumina HiSeq 2000 sequencer.
Isolation of liver macrophages and hepatocytes from mice
Liver macrophages and hepatocytes were isolated as previously described. Briefly, the livers of anesthetized mice were first perfused with calcium‐free Hank's balanced salt solution (HBSS), followed by collagenase digestion. After digestion, hepatocytes were released by mechanical dissociation of the lobes and underwent several steps of filtration with calcium‐containing HBSS and centrifugation at 50 g for 3 min. The resulting hepatocyte pellet was washed twice and plated. The supernatant containing non‐parenchymal cells was loaded onto a Percoll gradient (25 and 50%) and centrifuged at 2,300 rpm for 30 min at 4°C. The interphase ring with enriched liver macrophages was collected. Cells were then plated for 30 min and washed twice before RNA or protein was extracted for subsequent analyses.
Isolation of liver macrophages from humans
Freshly obtained liver biopsies were cut into small pieces and immediately digested in RPMI medium containing collagenase II (0.25 mg/ml; Sigma, C6885) and DNase I (0.2 mg/ml; Roche, 1010415900) at 37°C for 30 min. Single‐cell suspensions were filtered through a cell strainer (75 μm) and centrifuged at 50
g for 3 min. The supernatant containing non‐parenchymal cells was loaded onto a Percoll gradient and liver macrophages were isolated as described above. For details concerning this experiment view part Methods and Supplementary Methods in (Tencerova,
2020).
GeRP administration by intravenous injection in vivo
Glucan shells (GS) were prepared by using a previously published protocol (Tesz
et al,
2011). Briefly, 100 g of baker's yeast (
Saccharomyces cerevisiae, SAF‐Mannan, Biospringer) was heated at 80–85°C for 1 h in 1 l of NaOH (0.5 M) to hydrolyze the outer cell wall and intracellular components. This step was repeated after a water wash. Following centrifugation (15,000
g for 10 min), the resulting pellet was washed at least three times with water and three times with isopropanol. This yielded approximately 3–4 mg of purified, porous 2‐ to 4‐μm, hollow β 1,3‐d‐glucan particles. One gram of empty β1,3‐d‐glucan particles resuspended in 100 ml of sodium carbonate buffer was then labeled with FITC by incubation with 10 mg of 5‐(4,6‐dichlorotriazinyl) amino fluorescein (DTAF) dissolved in 10 ml of ethanol for ~16 h protected from light. Labeled GS were then washed at least five times in water. Wild‐type mice fed an HFD for 8 weeks were first randomized according to their body weight and glucose tolerance. Mice were then treated with 12.5 mg/kg GeRPs loaded with siRNA (247 μg/kg) and Endoporter (2.27 mg/kg). Mice received six doses of fluorescently labeled GeRPs by intravenous injection over 15 days. For details concerning this experiment view part Methods and Supplementary Methods in (Tencerova,
2020).
Human liver spheroids and IGFBP7 administration
Cryopreserved primary human hepatocytes (Bioreclamation IVT) were cultured in 96‐well ultra‐low attachment plates (Corning) as previously described (Tencerova,
2020). Briefly, 1,500 cells/well were seeded in culture medium (Williams' medium E containing 11 mM glucose supplemented with 2 mM l‐glutamine, 100 U/ml penicillin, 100 μg/ml streptomycin, 10 μg/ml insulin, 5.5 μg/ml transferrin, 6.7 ng/ml sodium selenite, and 100 nM dexamethasone) with 10% FBS as described previously. Following aggregation, cells were transitioned into serum‐free Williams' medium E (PAN‐Biotech) containing 5.5 mM glucose and 1 nM insulin for 7 days. On the day of the treatment, after 2 h of starvation, cells were exposed to recombinant human IGFBP7 (200 ng/ml; K95R, R&D Systems, 1334‐B7‐025 or wild type, R&D Systems, custom made) or insulin (100 nM) as reported previously (Tencerova,
2020). Protein was collected for immunoprecipitation assays and western blot analysis. Spheroid viability was controlled by ATP quantification using the CellTiter‐Glo Luminescent Cell Viability Assay (Promega) with values normalized to the corresponding vehicle control on the same plate. No statistically significant differences in viability were observed between IGFBP7‐ and vehicle‐treated controls when using heteroscedastic two‐tailed
t‐tests (
n = 8 spheroids) and
P < 0.05 as the significance threshold (Morgantini
et al,
2019). For analysis of lipoprotein production, the media were harvested and the level of LDL and VLDL was measured according to the manufacturer's protocol (Human Very Low‐Density Lipoprotein [LDL] and Human Very Low‐Density Lipoprotein [VLDL] Elisa Kit, respectively; Abbexa).
Statistics
Box plots, heat maps, and donut graphs were generated in GraphPad Prism9 software. 2way ANOVA was used for multiple comparison testing, followed by Tukey's or Šídák's multiple comparisons tests. Ordinary one‐way ANOVA followed by Dunnett's multiple comparisons test was used to compare the results with the corresponding control group. An unpaired t‐test was used for pair reciprocal comparison of datasets. Bar plots display mean and standard deviation. The statistical significance of the test is depicted in plots by using the following GP code (
P < 0.05 = *;
P < 0.001 = **;
P < 0.0001 = ***). Normality and homogeneity of variations were tested by the Anderson‐Darling test, D'Agostino Pearson's test, and Shapiro–Wilk test. Data showing significant deviances from normal distribution was normalized by Log
2‐transformation. For survival analyses, the data sets were compared by Log‐rank and Grehan‐Breslow Wilcoxon test. For complex differential analysis of omics data, we processed the data through an online platform for transcriptomic data analysis TCC (Sun
et al,
2013)—based on the following R‐packages (
edgeR,
DESeq,
baySeq, and
NBPSeq), iDep95 (Ge
et al,
2018)—based on the following R‐packages (
limma,
DESeq2,
GSEA,
PAGE,
GACE,
RactomePA,
Kallisto,
Galaxy) followed by subsequent analysis of assigned biological processes in Kegg pathways (
www.genome.jp/kegg/pathway) and Flymine databases (
https://www.flymine.org/flymine). An online platform for lipidomic data analysis (LipidSuite (Mohamed & Hill,
2021) – based on the R‐package
lipidr) was employed for differential comparison of obtained lipidomic datasets.
List of primers and other nucleotide sequences used in this work:
Genotypes of experimental models
(A–F) Hml>Gal4; TubGal80TS x TRiPcontrol refers to
w1118/+;
HmlΔ‐Gal4/+;
P{tubPGal80ts}/
TRiPcontrolHml>Gal4; TubGal80TS x Wcontrol corresponds to w1118/w1118; HmlΔ‐Gal4/+; P{tubPGal80ts}/+
(H, I) Crq>Gal4; UAS2xGFP x TRiPcontrol refers to +/+; +/+;
Crq‐Gal4,
UAS‐2xeGFP/
TRiPcontrolCrq>Gal4; UAS2xGFP x Wcontrol corresponds to w1118/w1118; Crq‐Gal4, UAS‐2xeGFP/+
(A–C) Crq>Gal4; UAS‐GFP corresponds to +/+; +/+; Crq‐Gal4, UAS‐2xeGFP/Crq‐Gal4, UAS‐2xeGFP
(D) ImpL2>mCherry corresponds to w1118/w1118; 20xUAS‐6xmCherry/+; ImpL2‐Gal4/+
(E) Crq>Gal4; UAS‐GFP x Wcontrol corresponds to w
1118/+; +/+; Crq‐Gal4, UAS‐2xeGFP/+
Crq>Gal4; UAS‐GFP x Hif1αRNAi corresponds to w1118/+; +/+; UAS‐Hif1αRNAi/Crq‐Gal4 UAS‐2xeGFP
(F) Crq> Gal4; UAS‐SimaGFP refers to w1118/w1118; +/PBac{sima‐GFP.AC.FPTB}VK00037; Crq‐Gal4 UAS‐2xeGFP/+
(A–F) Hml>Gal4; TubGal80TS x TRiPcontrol refers to
w1118/+;
HmlΔ‐Gal4/+;
P{tubPGal80ts}/
TRiPcontrolHml>Gal4; TubGal80TS x Wcontrol corresponds to w1118/w1118; HmlΔ‐Gal4/+; P{tubPGal80ts}/+
Hml>Gal4; TubGal80TS > ImpL2CDS corresponds to w1118/w1118; HmlΔ‐Gal4/+; P{tubPGal80ts}/UAS‐ImpL2cds
Hml>Gal4; TubGal80TS > ImpL2RNAi corresponds to w1118/+; HmlΔ‐Gal4/UAS‐ImpL2RNAi; P{tubPGal80ts}/+
(A) Hml>Gal4; TubGal80TS x TRiPcontrol refers to
w1118/+;
HmlΔ‐Gal4/+;
P{tubPGal80ts}/
TRiPcontrolHml>Gal4; TubGal80TS x Wcontrol corresponds to w1118/w1118; HmlΔ‐Gal4/+; P{tubPGal80ts}/+
Hml>Gal4; TubGal80TS > ImpL2CDS corresponds to w1118/w1118; HmlΔ‐Gal4/+; P{tubPGal80ts}/UAS‐ImpL2cds
Hml>Gal4; TubGal80TS > ImpL2RNAi corresponds to w1118/+; HmlΔ‐Gal4/UAS‐ImpL2RNAi; P{tubPGal80ts}/+
(B–D) Hml>Gal4 TubGal80TS x Wcontrol corresponds to
w1118/
w1118;
HmlΔ‐Gal4 P{tubPGal80ts}/+; +/+
Hml>Gal4 TubGal80TS x ImpL2CDS corresponds to w1118/w1118; HmlΔ‐Gal4 P{tubPGal80ts}/+; UAS‐ImpL2cds/+
Hml>Gal4 TubGal80TS x foxoBG01018 ImpL2CDS refers to w1118/w1118; HmlΔ‐Gal4 P{tubPGal80ts}/+; P{w[+mGT]=GT1}foxoBG01018 UAS‐ImpL2cds/+
(A, B) Hml>Gal4 TubGal80TS; tGPH‐GFP x w1118 corresponds to
w1118/
w1118;
HmlΔ‐Gal4 P{tubPGal80ts}/+;
tGPH/+
Hml>Gal4 TubGal80TS; tGPH‐GFP x ImpL2CDS corresponds to w1118/w1118; HmlΔ‐Gal4 P{tubPGal80ts}/+; tGPH/UAS‐ImpL2cds
Hml>Gal4 TubGal80TS; tGPH‐GFP x ImpL2RNAi corresponds to w1118/w1118; HmlΔ‐Gal4 P{tubPGal80ts}/+; tGPH/ImpL2RNAi
(C, D) FB>Gal4 TubGal80TS x W1118 corresponds to
w1118/+;
FB‐Gal4/+;
P{tubPGal80ts}/+
FB>Gal4 TubGal80TS x TRiPcontrol refers to +/+; FB‐Gal4/+; P{tubPGal80ts}/TRiPcontrol
FB>Gal4 TubGal80TS x InRCA corresponds to +/+; FB‐Gal4/+; P{tubPGal80ts}/P{w[+mC]=UAS‐InR.K1409A}3
FB>Gal4 TubGal80TS x InRDN refers to +/+; FB‐Gal4/P{w[+mC]=UAS‐InR.A1325D}2; P{tubPGal80ts}/+
FB>Gal4 TubGal80TS x PTENCDS corresponds to to +/+; FB‐Gal4/+; P{tubPGal80ts}/M{UAS‐Pten.ORF.3xHA}ZH‐86Fb
Hml>Gal4 TubGal80TS x foxoBG01018 ImpL2CDS refers to w1118/w1118; HmlΔ‐Gal4 P{tubPGal80ts}/+; P{w[+mGT]=GT1}foxoBG01018 UAS‐ImpL2cds/+
Hml>Gal4 TubGal80TS x foxoBG01018 refers to w1118/w1118; HmlΔ‐Gal4 P{tubPGal80ts}/+; P{w[+mGT]=GT1}foxoBG01018/P{w[+mGT]=GT1}foxoBG01018
(F, G) FB>Gal4 TubGal80TS x TRiPcontrol refers to +/+;
FB‐Gal4/+;
P{tubPGal80ts}/
TRiPcontrolFB>Gal4 TubGal80TS x InRCA corresponds to +/+; FB‐Gal4/+; P{tubPGal80ts}/P{w[+mC]=UAS‐InR.K1409A}3
FB>Gal4 TubGal80TS x MtpRNAi refers to +/+; FB‐Gal4/P{y[+t7.7] v[+t1.8]=TRiP.HMC03446}attP40; P{tubPGal80ts}/+
FB>Gal4 TubGal80TS x apoLTPRNAi refers to +/+; FB‐Gal4/+; P{tubPGal80ts}/P{y[+t7.7]v[+t1.8]=TRiP.HMC03294}attP2
FB>Gal4 TubGal80TS x apoLPPRNAi corresponds to +/+; FB‐Gal4/+; P{tubPGal80ts}/P{y[+t7.7] v[+t1.8]=TRiP.HM05157}attP2
(A‐D) Crq>GFP x ImpL2RNAi refers to w
1118/+; UAS‐ImpL2
RNAi/+; Crq‐Gal4, UAS‐2xeGFP/+
Crq>GFP x ImpL2cds corresponds to w1118/w1118; +/+; Crq‐Gal4, UAS‐2xeGFP/UAS‐ImpL2cds
Crq>GFP x TRiPcontrol refers to +/+; +/+; Crq‐Gal4, UAS‐2xeGFP/TRiPcontrol
Crq>GFP x W1118 corresponds to w1118/w1118; Crq‐Gal4, UAS‐2xeGFP/+
(E‐F) Hml>Gal4; TubGal80TS x TRiPcontrol refers to w
1118/+; HmlΔ‐Gal4/+; P{tubPGal80ts}/TRiP
controlHml>Gal4; TubGal80TS x Wcontrol corresponds to w1118/w1118; HmlΔ‐Gal4/+; P{tubPGal80ts}/+
Hml>Gal4; TubGal80TS x ImpL2CDS corresponds to w1118/w1118; HmlΔ‐Gal4/+; P{tubPGal80ts}/UAS‐ImpL2cds
Hml>Gal4; TubGal80TS x ImpL2RNAi corresponds to w1118/+; HmlΔ‐Gal4/UAS‐ImpL2RNAi; P{tubPGal80ts}/+
(A) FB>Gal4 TubGal80TS x LPPRNAi corresponds to +/+; FB‐Gal4/+; P{tubPGal80ts}/P{y[+t7.7] v[+t1.8]=TRiP.HM05157}attP2
Wcontrol x FB>Gal4 TubGal80TS corresponds to w1118/+; FB‐Gal4/+; P{tubPGal80ts}/+
LPPRNAi x Wcontrol corresponds to w1118/+; +/+; +/P{y[+t7.7] v[+t1.8]=TRiP.HM05157}attP2
(B–D) FB>Gal4 TubGal80TS x LPPRNAi corresponds to +/+; FB‐Gal4/+; P{tubPGal80ts}/P{y[+t7.7] v[+t1.8]=TRiP.HM05157}attP2
Wcontrol x FB>Gal4 TubGal80TS corresponds to w1118/+; FB‐Gal4/+; P{tubPGal80ts}/+
(E, F) Crq>Gal4; UAS‐GFP corresponds to +/+; +/+; Crq‐Gal4, UAS‐2xeGFP/Crq‐Gal4, UAS‐2xeGFP